Nuclear medicine equipment market seen reaching $3.67 billion by 2030

The global nuclear medicine equipment market is projected to rise from $2.97 billion in 2026 to $3.67 billion by 2030, driven by cancer care, cardiovascular disease and the shift toward precision medicine. North America leads the market now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Nuclear medicine equipment is central to diagnosing and treating disease with radioactive materials, especially in cancer and cardiovascular care. - Market growth points to rising demand for more precise imaging, targeted therapy and outpatient services. - The expansion also signals broader adoption of hybrid imaging and theranostics in modern healthcare.

What happened: - The Business Research Company said the nuclear medicine equipment market is projected to grow from $2.97 billion in 2026 to $3.67 billion by 2030. - The forecast implies a 5.4% compound annual growth rate over the period. - The market was estimated at $2.81 billion in 2025. - The company published the update on Aug. 20, 2026. - The report is available through a free sample and a full market report.

The details: - Nuclear medicine equipment uses radioactive substances to image organs and tissues or deliver targeted radiation therapy. - The equipment supports early detection, treatment planning and ongoing monitoring. - The report ties near-term growth to an aging population, higher cancer rates, wider use of diagnostic imaging, hospital infrastructure expansion and government support for nuclear medicine technologies. - Future demand is expected to come from theranostics, precision medicine, hybrid imaging, cardiovascular disease and imaging-center growth in emerging markets. - The report flags advanced hybrid imaging systems, broader theranostics use, personalized nuclear diagnostics, lower radiation doses and outpatient nuclear imaging as major trends. - North America held the largest market share in 2025. - Asia-Pacific is forecast to grow at the fastest pace in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Cardiovascular disease is becoming a bigger demand driver because nuclear medicine can improve early diagnosis and disease staging. - The Business Research Company pointed to UK data from the British Heart Foundation showing about 7.6 million people live with heart and circulatory conditions, with these diseases causing about 27% of deaths in the UK. - That burden helps explain why cardiac imaging remains a key use case for the market. - The focus on TAM scoring, company matrices and forecasting dashboards suggests buyers want more decision tools, not just market size estimates.

What's next: - Growth is likely to track investment in imaging centers, especially across Asia-Pacific and other emerging markets. - Product development will likely center on more advanced hybrid systems and personalized diagnostics. - Providers are expected to keep pushing toward lower radiation exposure and more outpatient use.

The bottom line: - Nuclear medicine equipment is moving from a niche diagnostic category to a core part of precision care, with steady global growth expected through 2030.